GenCure Revenue and Competitors
Estimated Revenue & Valuation
- GenCure's estimated annual revenue is currently $3.3M per year.
- GenCure's estimated revenue per employee is $81,600
Employee Data
- GenCure has 40 Employees.
- GenCure grew their employee count by -5% last year.
GenCure's People
Name | Title | Email/Phone |
---|---|---|
1 | Project Manager - Design and Development | Reveal Email/Phone |
2 | Process Development Associate: CDMO | Reveal Email/Phone |
GenCure Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.7M | 33 | -17% | N/A | N/A |
#2 | $5.2M | 57 | 4% | N/A | N/A |
#3 | $1.8M | 25 | -11% | N/A | N/A |
#4 | $1.7M | 24 | 9% | N/A | N/A |
#5 | $2.1M | 29 | -3% | N/A | N/A |
#6 | $1.1M | 18 | -14% | N/A | N/A |
#7 | $3M | 37 | -18% | N/A | N/A |
#8 | $6.3M | 69 | -3% | N/A | N/A |
#9 | $32.4M | 289 | 5% | N/A | N/A |
#10 | $84M | 659 | 6% | N/A | N/A |
What Is GenCure?
GenCure is a subsidiary of BioBridge Global, a not-for-profit organization with a mission to save and enhance lives through the healing power of human cells. GenCure is focused on enabling the development of regenerative medicine therapies and companies by providing access to source materials, cGMP manufacturing experience and clinical trials support. We were formally established in 2015 to build upon the regenerative medicine elements of our existing services in tissue, cord blood, cellular therapy, marrow and apheresis collections.
keywords:N/AN/A
Total Funding
40
Number of Employees
$3.3M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
GenCure News
... now houses the biomanufacturing firm GenCure and gene-therapy company Scorpion Biologics, among other biotech and health care startups.
Its tenants include gene-therapy company Scorpion Biological Services, therapeutics firm GenCure and startups in an incubator.
GenCure's biomanufacturing services team has successfully completed a production run expanding and harvesting human mesenchymal stem ...
San Antonio, Texas, Aug. 13, 2019 (GLOBE NEWSWIRE) -- In a breakthrough for the regenerative medicine industry, GenCure announced ...
VelocityTX will be housed in the Merchant's Ice House along with tenant GenCure, an offshoot of San Antonio's BioBridge Global that works in ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.6M | 40 | -13% | N/A |
#2 | N/A | 40 | -20% | N/A |
#3 | $9.3M | 40 | -18% | N/A |
#4 | $8.1M | 40 | 38% | N/A |
#5 | $10.3M | 40 | 3% | N/A |